Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fabry Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02798458
What this trial is testing

Evaluation of the Gastrointestinal Manifestation of Fabry's Disease

Who this might be right for
Fabry's Disease
Massachusetts General Hospital 48
Not applicableLooking for participantsNCT06663358
What this trial is testing

A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 100
Not applicableStudy completedNCT01745185
What this trial is testing

Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta

Who this might be right for
Fabry Disease
O & O Alpan LLC 30
Not applicableLooking for participantsNCT06607471
What this trial is testing

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.

Who this might be right for
Non-ischemic CardiomyopathyDilated Cardiomyopathy (DCM)Hypertrophic Cardiomyopathy (HCM)+12 more
Scientific Institute San Raffaele 15,000
Not applicableStudy completedNCT00446862
What this trial is testing

The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

Who this might be right for
Fabry DiseaseProteinuria
University of Alabama at Birmingham 36
Early research (Phase 1)Study completedNCT01730482
What this trial is testing

Assess the Absorption, Metabolism and Excretion of Migalastat Hydrochloride (AT1001-014)

Who this might be right for
Fabry Disease
Amicus Therapeutics 6
Not applicableStudy completedNCT04050137
What this trial is testing

Therapeutic Exercise to Treat Neuropathic Pain

Who this might be right for
Gaucher DiseaseFabry Disease
Universidad de Zaragoza 5
Not applicableLooking for participantsNCT07336394
What this trial is testing

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

Who this might be right for
Danon DiseaseFabry DiseaseCardiac Amyloidosis+4 more
Chinese Academy of Medical Sciences, Fuwai Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT01304277
What this trial is testing

This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.

Who this might be right for
Fabry Disease
Shire 17
Not applicableUnknownNCT01695161
What this trial is testing

Non-invasive Assessment of Intraocular Pressure in MPS by Use of the Ocular Response Analyzer.

Who this might be right for
MucopolysaccharidosisFabry Disease
Johannes Gutenberg University Mainz 75
Not applicableUnknownNCT03812042
What this trial is testing

Screening of Lysosomal Storage Disorders Diseases in Minority Groups

Who this might be right for
Lysosomal Storage Diseases
Lysosomal and Rare Disorders Research and Treatment Center, Inc. 100,000
Testing effectiveness (Phase 2)Study completedNCT00283959
What this trial is testing

A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 4
Not applicableWithdrawnNCT01429597
What this trial is testing

Fabry and Cardiomyopathy (FaCard)

Who this might be right for
Cerebrovascular AccidentStroke, AcuteCerebral Stroke
CENTOGENE GmbH Rostock
Not applicableStudy completedNCT04602364
What this trial is testing

French Prospective, Observational Cohort Study of Patients With Fabry Disease Treated With Migalastat

Who this might be right for
Fabry Disease
Amicus Therapeutics France SAS 48
Not applicableUnknownNCT02883205
What this trial is testing

Diagnosis of Fabry Disease: Impact of an Educational Brochure Intended for Cardiologist

Who this might be right for
Cardiomyopathies
University Hospital, Caen 50
Large-scale testing (Phase 3)Study completedNCT03425539
What this trial is testing

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

Who this might be right for
Fabry Disease
Idorsia Pharmaceuticals Ltd. 118
Not applicableLooking for participantsNCT07382128
What this trial is testing

Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

Who this might be right for
HCM - Hypertrophic CardiomyopathyAnderson Fabry DiseaseCardiac Magnetic Resonance Imaging+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 250
Not applicableLooking for participantsNCT06758648
What this trial is testing

Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study

Who this might be right for
Fabry DiseaseEndothelial DysfunctionMicrovasculature
Technical University of Munich 63
Large-scale testing (Phase 3)Active Not RecruitingNCT04020055
What this trial is testing

Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 14
Not applicableUnknownNCT04639999
What this trial is testing

Impact of MIgalastat TheRApy on CaRdiac Function in patiEnts With Fabry's Cardiomyopathy (MIRACRE-Fabry Trial)

Who this might be right for
Fabry Disease
Yonsei University 20
Next Page